Haemophilia

Some people bleed for a long time.

This happens because their blood cannot clot well. Clotting helps stop bleeding after an injury.

People may get big bruises easily. They might also bleed inside their joints. This can cause pain or damage.

Most people get this from their parents. It is much more common in men. Girls can have it too, but it is rare.

Doctors can help by giving special medicine. This medicine helps the blood clot again. It can be given at home or in a hospital.

Some people have a condition called haemophilia. This condition makes it hard for blood to clot. Clotting is the way the body stops bleeding after an injury.

When blood cannot clot well, people may bleed for a long time. They might get big bruises very easily. Some people bleed inside their joints. This can cause pain or even permanent damage. Bleeding in the brain is also a serious risk.

There are different types of this condition. Haemophilia A happens when there is not enough clotting factor VIII. Haemophilia B happens when there is low clotting factor IX. People can also get it from a new mutation. This is a change in the body's instructions that happens on its own.

Most people get haemophilia from their parents. It is passed down through X chromosomes. This is why it is more common in men.

Doctors treat it by replacing the missing parts. They give medicine that contains the clotting factors. This can be done at home or in a hospital.

Haemophilia is a condition that changes how the body handles bleeding. Usually, when you get a cut, your blood works to make a clot. A clot acts like a natural bandage to stop the bleeding. For people with haemophilia, this process does not work quite right. They may bleed for a much longer time after an injury. They might also get bruises very easily.

There are different ways this condition works in the body. Haemophilia A happens when there is a low amount of clotting factor VIII. Haemophilia B occurs when there are low levels of clotting factor IX. There is also haemophilia C, which involves factor XI. These factors are parts of the blood that help the clotting pathway work. This pathway is very important when a blood vessel is damaged.

Most people inherit this condition from their parents. It is passed down through X chromosomes. This is why it is mostly found in men. A man only needs one affected X chromosome to have the disorder. A woman would need two affected X chromosomes to be affected. Because of this, many women are just carriers. They have one healthy gene that provides enough clotting factors.

History shows us how this condition has moved through families. In the 1800s, haemophilia B was common in European royal families.

Scientists later learned more about the different types. They determined the difference between haemophilia A and B in 1952. Today, we know that about 1 in 5,000 to 10,000 males have haemophilia A. About 1 in 40,000 males are born with haemophilia B.

Doctors have many ways to help people with haemophilia today. They can replace the missing clotting factors with medicine. This can happen in a hospital or even at home. Some people use a medicine called desmopressin for mild cases. Scientists are even testing gene therapy to help treat the condition. This new way of treating it is being studied in clinical trials.

Haemophilia is a genetic disorder that impairs the body's ability to form blood clots. Clotting is a vital process used to stop bleeding after an injury. When a person has haemophilia, they may bleed for a longer duration following an accident. They often experience easy bruising and face increased risks of internal bleeding. This bleeding can occur inside joints or even within the brain.

To understand how this works, we must look at the intrinsic pathway. This is a specific sequence of steps the blood follows to create a clot. The pathway is necessary when there is damage to the endothelium, which is the lining of a blood vessel. In people with haemophilia, certain clotting factors are missing or low. This prevents the pathway from functioning properly. Without these factors, the body cannot build a stable clot to seal the wound.

There are several distinct types of this condition based on which factor is missing. Haemophilia A is the most common and occurs due to low levels of clotting factor VIII. Haemophilia B occurs because of low levels of clotting factor IX. There is also haemophilia C, which involves low levels of factor XI. Other rare forms include parahaemophilia, caused by low factor V, and Von Willebrand disease.

The severity of the disorder depends on how much active factor remains in the blood. People with less than 1% active factor are classified as having severe haemophilia. Those with 1% to 5% active factor have moderate haemophilia. People with between 5% and 40% of normal levels have mild haemophilia. Severe cases often involve spontaneous bleeding, which happens without any obvious injury. This can lead to joint bleeds, where blood enters the joint spaces.

Haemophilia is typically an X-linked recessive disorder. This means the genes for clotting factors are located on the X chromosome. Because males have only one X chromosome, a single faulty gene will cause the disease. Females have two X chromosomes, so a healthy gene can often mask a faulty one. This makes females much more likely to be "carriers" rather than being affected themselves. However, a female can be affected if she inherits two faulty X chromosomes.

History shows how this condition has traveled through generations. In the 1800s, haemophilia B was common among the royal families of Europe.

Scientists made a major breakthrough in 1952 when they determined the difference between haemophilia A and B. Today, we know the specific frequency of these conditions. Haemophilia A affects about 1 in 5,000 to 10,000 males. Haemophilia B affects approximately 1 in 40,000 males at birth.

Medical treatments have changed significantly over time. Doctors treat the condition by replacing the missing clotting factors. These factors can be made from human blood or through recombinant methods.

Some patients use a medication called desmopressin for mild haemophilia A. Scientists are also conducting clinical trials for gene therapy. This new approach aims to provide a long-term solution by addressing the underlying genetic cause.

Managing the condition is essential to prevent serious complications. Severe joint bleeds can lead to permanent damage or disfigurement through a process called haemarthrosis. This can cause the destruction of cartilage and bone. Internal bleeding in the brain, or intracranial haemorrhage, is a medical emergency. It can cause pressure inside the skull, leading to seizures or loss of consciousness.

Modern medicine helps many people live full lives by managing these risks through regular factor replacement.